Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19The Motley Fool • 03/25/20
Covid Report: Gilead Asks FDA To Rescind Key Status For Coronavirus DrugInvestors Business Daily • 03/25/20
Covid Report: Overtaxed, Gilead Suspends Access To Coronavirus DrugInvestors Business Daily • 03/23/20
Deep Dive: You can be ‘practically stealing’ quality stocks now, according to JefferiesMarket Watch • 03/23/20
15 Stocks Still Rising Against the Roaring Bear Market and the Coronavirus24/7 Wall Street • 03/22/20